drugset / Trial / NCT02183077
Pharmacokinetics and Tolerability of Meloxicam Gel Compared to Meloxicam Tablets in Healthy Subjects
RandomizedCrossoverOpen-labelTreatment
Summary
Study to gain information on the percutaneous absorption of meloxicam after administration of a topical gel over 7 days.
Timeline
- Start
- 1998-09
- Primary completion
- 1998-11
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Meloxicam | Small molecule | 7.5 mg | Topical |
| Subject | Meloxicam | Small molecule | 15 mg | Topical |
Indications
No indication recorded.